In light of its function as an amino acid transporter, it is not surprising that xCT is implicated in the metabolic reprogramming of cancer cells and adaptation to nutrient availability in the tumor microenvironment, and many studies have uncovered an unexpected weakness in cancer cells cultured under glucose deprivation conditions [21,22,23]. This evidence concerns the gene SLC7A11 and cancer.